HOME
PRODUCT
SOLUTION
SUPPORT
SHOP
ABOUT
CONTACT
2024-05-29
By celnovte
Share to:
TTF1
Celnovte self-cloned primary antibodies won optimal in NordiQC assessment.
Certificate of IVD Notification
Celnovte CD10 NordiQC Assessment